Philip Linden, MD
- Associate Professor
- Division Chief, Thoracic and Esophageal Surgery
Philip Linden, MD, is the Chief of the Division of Thoracic and Esophageal Surgery at University Hospitals and UH Seidman Cancer Center. He is an associate professor of surgery at Case Western Reserve University School of Medicine.
Dr. Linden is board certified in general surgery and thoracic surgery. His clinical interests include minimally invasive chest surgery, lung and esophageal cancer, the treatment of emphysema, and high-risk thoracic surgery.
Dr. Linden earned a bachelor’s degree from Williams College in Massachusetts, completed medical school at the University of Pennsylvania, and trained in general surgery at Brigham and Women’s Hospital and Harvard Medical School. He was a research fellow for two years at Boston Children’s Hospital and Harvard Medical School. He completed his thoracic surgery training at Brigham and Women’s Hospital, Boston Children’s Hospital, and Harvard Medical School in 2001. After completing his training, he was hired as a staff surgeon at Brigham and Women’s Hospital and was an associate professor of surgery at Harvard Medical School.
Dr. Linden came to University Hospitals in 2007 to help create and lead the Division of Thoracic and Esophageal Surgery. Since that time, the division has grown to include six thoracic surgeons, caring for patients throughout Northeast Ohio. The division is consistently ranked among the top 10 percent of programs in the nation.
Dr. Linden has authored numerous publications and presented his work in national and international forums. He is the recipient of the Richard Clark Award given by the Society of Thoracic Surgery for outstanding research.
- Ablative Therapies
- Lung Cancer in the Emphysema Patient
- Minimally Invasive Lung and Esophageal Surgery
- Thoracic Cancer
Patient Satisfaction Reviews
4.9 out of 5
- Thoracic Surgery - American Board of Surgery
- Surgery - American Board of Surgery
Residency | Cardiac Surgery/Chief Resident
Cardiac Surgery/Chief Resident - Brigham And Women's Hospital (2000 - 2001)
Fellowship | Cardiothoracic Surgery
Cardiothoracic Surgery - Brigham And Women's Hospital (1999 - 2000)
Residency | General Surgery
General Surgery - Brigham And Women's Hospital (1997 - 1999)
Research Fellowship | General Surgery
General Surgery - Brigham And Women's Hospital (1995 - 1997)
Residency | General Surgery
General Surgery - Brigham And Women's Hospital (1993 - 1995)
Internship | General Surgery
General Surgery - Brigham And Women's Hospital (1992 - 1993)
University Of Pennsylvania School Of Medicine (1992)
Williams College (1988)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Philip Linden disclosed the following Outside Relationships with Industry:
- - Acuity Bio - Ownership